NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Sahajanand Medical Technologies (SMT)
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Six Month Clinical Outcomes of SMT’s Supralimus-Sirolimus Eluting Stent Presented at EuroPCR 09 - Six Month Clinical Outcomes of SMT’s Supralimus-Sirolimus Eluting Stent with a Biodegradable Polymer (part of the prospective Multicenter E-Series Registry) is presented at EuroPCR 2009
Six Month Clinical Outcomes of SMT’s Supralimus-Sirolimus Eluting Stent Presented at EuroPCR 09

 

NewswireToday - /newswire/ - Surat, Gujarat, India, 2009/07/02 - Six Month Clinical Outcomes of SMT’s Supralimus-Sirolimus Eluting Stent with a Biodegradable Polymer (part of the prospective Multicenter E-Series Registry) is presented at EuroPCR 2009.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Six months outcome of Sahajanand Medical Technologies Supralimus-Sirolimus Eluting stent with Bioabsorbable Polymer was presented at EuroPCR 2009. This analysis was performed as a part of the prospective of E-Series Multicenter Registry. The dataset demonstrates excellent results in high risk patients with complex coronary lesions, including high procedural success rate (> 97%), and sustained safety.

Presented by Dr. Ricardo A. Costa, of Cardiovascular Research Center, Brazil, Preliminary clinical results at 6 months (60%) from Multicenter E-Series Registry demonstrate clinical effectiveness of Supralimus in preventing revascularization, with only 2% TVR (Target Vessel Revascularization) rate. There were no thrombosis events and no TVR/TLR in the Supralimus treated patient’s in-Hospital. The stent thrombosis rate (definite/probable, ARC) up to 6 months was less than 1%.
Out-of Hospital adverse events (N=718) included only 2% Cardiac Death, 0.5% MI (Myocardial infarction) and 4.5% of MACE (Major Cardiac Adverse Event). Thus the preliminary data with the Supralimus-Sirolimus Eluting Stent has shown promising results.

The Study was conducted by Dr. Alexandre Abizaid, Dr. Ricardo Costa and others from Jan 2007 which involved 1181 Patients with 1260 lesions and prospectively enrolled in 50 cities of Brazil, Venezuela and India. The included patients were real world scenario with routine or emergency PCI. Mean age of patients was 64 years & risk factors included 79% Hypertension, 38% Diabetes, 31% Smoker, 23% with Previous MI, 64% with Dyslipidemia, 34% with Previous PCI and 46% with Family History of CAD. Clinical follow was scheduled at 1, 6, 12 and 24 months. Final analysis of this registry is awaited with great hope & promise.

About Sahajanand Medical Technologies
Established in the year 1998, company (smtpl.com) became the first Indigenous Stent Manufacturer in world to have two DES systems in its product portfolio. It is India’s largest manufacturing company based on Evidence Based Implantable Medical Devices and Medical Equipments. The products are manufactured conforming to the international quality standards and are offered at the most competitive prices. The Company is ISO 9000 certified & also obtained CE certification for its advanced range of products. This gives assurance of company’s quality consciousness.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Sahajanand Medical Technologies (SMT)

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Six Month Clinical Outcomes of SMT’s Supralimus-Sirolimus Eluting Stent Presented at EuroPCR 09

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: J P Dutta - SahMed.com 
+91 26 12451451 pr[.]sahmed.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sahajanand Medical Technologies (SMT) securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Sahajanand Medical Technologies (SMT) / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Bruker Launches the Q4 POLO - Compact Spark-OES Metals Analyzer
Respiratory Health Management Market to Expedite Digital, Smart, and Portable Solutions Says Frost & Sullivan
Bruker Joins PANACEA Network to Broaden Access to NMR for European Chemistry Community
High-end Global Computed Tomography Purchases to Propel the High-end CT Segment Revenue Finds Frost & Sullivan
KRAIBURG TPE Introduces Ergonomically Designed Healthcare Equipment
Fujifilm Lauded by Frost & Sullivan for Disrupting the Operating Room Space with its Systems Integration Solution
BASF’s Irgastab® Enables LOTTE Chemical to Deliver High-clarity Medical Polypropylene for Syringes Used in COVID-19 Vaccinations
Withings and One Drop Partner to Bring Best-in-class Medical Devices to Multi-condition Employer Program
BIOTRONIK Applauded by Frost & Sullivan for its Disruptive Implantable Cardiac Monitoring Device, BIOMONITOR IIIm
Sensor Technologies for Pressure Injury Prevention Improve Outcomes and Operational Efficiency for Hospitals Finds Frost & Sullivan
New Bruker NMR Life Science Research Solutions Enable Functional Structural and Cellular Biology Research
Bruker Corporation Launches A New VIP-HESI Ion Source
US National Science Foundation’s (NSF) Division of Biological Infrastructure Announced An Award to Create A Novel ‘Network for Advanced NMR’ (NAN)
Device Companies will Drive Surgery Automation to Increase Elective Procedures in Western Europe Finds Frost & Sullivan
Bruker Launches TimsTOF TrueSCP for Unbiased Single Cell 4D-Proteomics and Next-gen TimsTOF Pro 2 with Unprecedented Proteomic Depth

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  JobsWare.com





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)